Raymond James Financial Services Advisors, Inc. Cidara Therapeutics, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $66.3 Billion
- Q1 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 77,553 shares of CDTX stock, worth $869,369. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,553
Previous 78,867
1.67%
Holding current value
$869,369
Previous $62,000
14.52%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CDTX
# of Institutions
53Shares Held
22.2MCall Options Held
2.7KPut Options Held
100-
Bvf Inc San Francisco, CA6.86MShares$76.9 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$37.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.55MShares$28.6 Million0.0% of portfolio
-
Alethea Capital Management, LLC San Diego, CA1.6MShares$17.9 Million1.21% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.25MShares$14 Million0.0% of portfolio
About Cidara Therapeutics, Inc.
- Ticker CDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,075,696
- Market Cap $786M
- Description
- Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...